Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Acute Minimally Differentiated Myeloid Leukemia (M0)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00838240
What this trial is testing

Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 114
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Early research (Phase 1)UnknownNCT00544999
What this trial is testing

Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Institut de Recherche Clinique sur les Cancers et le Sang 21
Testing effectiveness (Phase 2)Study completedNCT00003661
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 3
Testing effectiveness (Phase 2)Ended earlyNCT00673153
What this trial is testing

Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Fred Hutchinson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01235572
What this trial is testing

Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more
Fred Hutchinson Cancer Center 200
Large-scale testing (Phase 3)UnknownNCT00004128
What this trial is testing

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 2,000
Early research (Phase 1)Ended earlyNCT01904643
What this trial is testing

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University 17
Early research (Phase 1)Study completedNCT00131989
What this trial is testing

Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Large-scale testing (Phase 3)UnknownNCT00454168
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Leukemia
The Vaccine Company 244
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT00098826
What this trial is testing

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Study completedNCT00027872
What this trial is testing

Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more
National Cancer Institute (NCI) 125
Testing effectiveness (Phase 2)Study completedNCT00352365
What this trial is testing

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00005795
What this trial is testing

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Northwestern University 11
Testing effectiveness (Phase 2)Study completedNCT00006122
What this trial is testing

Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 106
Early research (Phase 1)Ended earlyNCT02049801
What this trial is testing

MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+12 more
Bruno C. Medeiros 1
Next Page